| Category | BioTech |
| Employees |
| TOTAL | $20M |
| FUNDING TOTAL | $20M |
| Venture Round, 6/12 Eli Lilly | $20M |
Novast Laboratories is a specialty pharmaceutical company based in both the United States and China, and focused on the development, manufacturing and commercialization of high quality products for global markets. It is led by a management team with extensive scientific and managerial experience, and successful track record of development of NDA and ANDA products at the U.S. -based global pharmaceutical companies. Novast has established, implemented, and maintained all its scientific and quality standards and systems according to the requirements of the US and EU. More importantly, it has built a diligent and dependable work culture with intellectual property protection, financial accounting, environmental, safety standards, and highest integrity and ethics.
